Mirae Asset Global Etfs Holdings Ltd. Stoke Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 53,411 shares of STOK stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,411
Previous 24,167
121.01%
Holding current value
$1.37 Million
Previous $160,000
278.75%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding STOK
# of Institutions
139Shares Held
57.6MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$138 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$138 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$131 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$118 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$112 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $1.01B
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...